fda glp-1 compounding warning letters october 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA Issues Warning Letter to

Continued awareness and ongoing public education about the risks of acetaminophen toxicity aim at further minimizing this hazard and increasing the medications safety profile ( Sidebar )

If you must freeze a reconstituted solution, you must first aliquot it into single-use portions to avoid this

Experience a complete skin wellness formula infused with essential antioxidants for a clear, radiant complexion

And GLP1s, you know, when the new drug comes out, they're too good to be true

Originally developed for medical purposes, different formulations of Sermorelin were approved by the FDA in 1990 and 1997 for the treatment of growth hormone deficiency in children

Some patients successfully maintain weight loss without medication, but only if they achieve durable changes in eating behavior and physical activity